S L James|A Sher - JoVE Visualize

Showing results (21-30 of 519) with videos related to

Pageof 52

Sort By:

Parasitology|January 1, 1989

Schistosome vaccines: current progress and future prospectsA Sher, S L James, R Correa-Oliveira, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigenE J Pearce, S L James, S Hieny, et al.

European Journal of Immunology|October 1, 1992

The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-betaR T Gazzinelli, I P Oswald, S Hieny, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982

Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stageA Sher, S L James, A J Simpson, et al.

Infection and Immunity|August 1, 1987

Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain miceS L James, R Correa-Oliveira, A Sher, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1986

Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccineE J Pearce, S L James, J Dalton, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995

Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activityM E Williams, P Caspar, I Oswald, et al.

Infection and Immunity|January 1, 1997

Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoniS F Ahmed, I P Oswald, P Caspar, et al.

Behring Institute Mitteilungen|February 1, 1991

Immunization against parasites: bridging the gap between attenuated and non-living vaccinesA Sher, R Gazzinelli, F Hakim, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994

Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxideI P Oswald, I Eltoum, T A Wynn, et al.

Pageof 52

Showing results (21-30 of 519) with videos related to

Sort By:

Pageof 52

Parasitology|January 1, 1989

Schistosome vaccines: current progress and future prospectsA Sher, S L James, R Correa-Oliveira, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigenE J Pearce, S L James, S Hieny, et al.

European Journal of Immunology|October 1, 1992

The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-betaR T Gazzinelli, I P Oswald, S Hieny, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982

Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stageA Sher, S L James, A J Simpson, et al.

Infection and Immunity|August 1, 1987

Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain miceS L James, R Correa-Oliveira, A Sher, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1986

Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccineE J Pearce, S L James, J Dalton, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995

Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activityM E Williams, P Caspar, I Oswald, et al.

Infection and Immunity|January 1, 1997

Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoniS F Ahmed, I P Oswald, P Caspar, et al.

Behring Institute Mitteilungen|February 1, 1991

Immunization against parasites: bridging the gap between attenuated and non-living vaccinesA Sher, R Gazzinelli, F Hakim, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994

Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxideI P Oswald, I Eltoum, T A Wynn, et al.

Pageof 52